RICHMOND, Virginia, December 1, 2016 – Venebio Group LLC, a Richmond, Virginia based life sciences research consultancy, has been awarded a research grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH). The $1.5 million grant is a Direct-to- Phase-II Small Business Innovation Research (SBIR) Grant and is aimed […]
Venebio featured on the cover of the Richmond Times-Dispatch Metro Business Section
RICHMOND, Virginia, October 31, 2016 – Venebio Group, LLC, was featured on the cover of the Richmond Times-Dispatch Metro Business Section. The accompanying article highlights the recent $1.5 million NIH grant for continual development of the Venebio Opioid Advisor. Click here to read the full article online, or download a PDF version.
Venebio releases Fact Sheet for Venebio Opioid Advisor
RICHMOND, Virginia, February 8, 2016 – Venebio Group, LLC, has published a Fact Sheet for their algorithm-based clinical decision support tool, Venebio Opioid Advisor.
Venebio subsidiary, algorithmRx, receives second year of two-year NIH grant
RICHMOND, Virginia, May 20, 2015 – algorithmRx, headquartered in Richmond, Virginia, announced today that it has received confirmation of funding for the second year of a research grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) as part of the NIH’s Small Business Innovation Research (SBIR) program. […]
Venebio’s Chief Medical Officer presents opioid overdose screening tool to American Academy of Pain Medicine
RICHMOND, Virginia, May 18, 2015 – Barbara K. Zedler, MD, Chief Medical Officer of Venebio Group, LLC, attended the American Academy of Pain Medicine’s (AAPM) 2015 meeting to present recent advancements in a Risk Index for Overdose or Serious Opioid-Induced Respiratory Depression (RIOSORD) developed for Venebio’s client Kaleo, Inc. RIOSORD was created using retrospective data […]
Venebio subsidiary, algorithmRx, selected to present at the NHLBI Regional Innovation Conference
RICHMOND, Virginia, September 23, 2014 – algorithmRx, headquartered in Richmond, Virginia, was selected by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to give presentations at NHLBI’s Regional Innovation Conference in Research Triangle Park. This by-invitation-only conference brings together small businesses, angel investors, venture capitalists, strategic partners and […]
Venebio subsidiary, algorithmRx, awarded second commercialization grant from Virginia Center for Innovative Technology
RICHMOND, Virginia, June 30, 2014 – algorithmRx, LLC, headquartered in Richmond, Virginia, recently announced that the Virginia Center for Innovative Technology (CIT) has awarded a second $50,000 grant to algorithmRx for its innovative new aRx Statin Advisor product. A total of 38 awards were made to organizations across Virginia from academia, the research community and […]
Venebio subsidiary, algorithmRx, awarded second grant from NIH for $1.5 million to further develop aRx Statin Advisor
RICHMOND, Virginia, May 12, 2014 – algorithmRx, headquartered in Richmond, Virginia, announced today that it has been awarded a research grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) as part of the NIH’s Small Business Innovation Research (SBIR) program. This new two-year grant is for nearly […]
Molly Ronayne Joins Venebio
RICHMOND, VA., May 27, 2014 – Venebio Group, LLC, a Richmond, Virginia based life-sciences consulting firm announced today that Ms. Molly Ronayne has been named Manager, Business Development for Venebio effective May 27, 2014. Molly will represent Venebio’s skilled team of senior scientists and facilitate communications between Venebio and its valued clients. In this position, […]